Pacific Biosciences Of California PACB
NASDAQ PACB
$2.20 +0.37 (+20.27%)
As of: Sep 30, 2026 · 10:25 AM EDT

Pacific Biosciences Of California (PACB) Net Margin (2010 - 2026)

Updated

Pacific Biosciences Of California (PACB) recorded Net Margin of -114.70% in Q2 2026, down 9.26 percentage points from -105.44% a year earlier and down 92.44 percentage points from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Net Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Pacific Biosciences Of California's Net Margin came in at -82.49% as of Jun 30, 2026, up 254.68 percentage points year-over-year; for FY2025, it came in at -341.47%, down 140.29 percentage points from FY2024.

  • Annual Net Margin has a five-year change of -378.74 percentage points (FY2020 to FY2025).
  • Across earlier years, Net Margin came in at -201.18% in FY2024 (-48.21 pp), -152.97% in FY2023 (+91.96 pp), -244.92% in FY2022 (-106.07 pp) and -138.85% in FY2021 (-176.12 pp).
  • The Q2 2026 figure is the lowest quarterly Net Margin since Q1 2025.
  • On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of +77.14 percentage points.
  • Peak year-over-year performance for Net Margin in the last five years was a gain of 1124.55 percentage points in Q1 2026, against a drop of 945.37 percentage points in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -22.26% (Q1 2026), -90.43% (Q4 2025) and -98.85% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 14.47%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 7.37%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 13.89%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 28.29%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 15.07%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 19.37%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 16.67%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 7.57%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 13.89%
10 Pacific Biosciences Of California 531.49 Mn -559.51 Mn 12.64 Mn -114.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114.70%
Mar 31, 2026 -22.26%
Dec 31, 2025 -90.43%
Sep 30, 2025 -98.85%
Jun 30, 2025 -105.44%
Mar 31, 2025 -1,146.81%
Dec 31, 2024 6.04%
Sep 30, 2024 -151.94%
Jun 30, 2024 -481.27%
Mar 31, 2024 -201.44%
Dec 31, 2023 -140.55%
Sep 30, 2023 -120.07%
Jun 30, 2023 -146.79%
Mar 31, 2023 -226.26%
Dec 31, 2022 -308.50%
Sep 30, 2022 -238.22%
Jun 30, 2022 -201.30%
Mar 31, 2022 -245.68%
Dec 31, 2021 -192.48%
Sep 30, 2021 47.42%
API Access

Pacific Biosciences Of California Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=PACB&period=max&api_key=YOUR_API_KEY